Genelux Corporation Common Stock
GNLX Real Time Price USDRecent trades of GNLX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by GNLX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
GNLX Revenue by Segment or Geography
New patents grants
-
Patent Title: Clonal strains of attenuated vaccinia viruses and methods of use thereof Oct. 19, 2021
-
Patent Title: Bioreactor production of virus from adherent cells Dec. 01, 2020
-
Patent Title: Modified vaccinia virus strains for use in diagnostic and therapeutic methods Mar. 10, 2020
-
Patent Title: Microorganisms for therapy Nov. 05, 2019
-
Patent Title: Oncolytic virus adjunct therapy with agents that increase virus infectivity Mar. 26, 2019
-
Patent Title: Modified vaccinia virus strains for use in diagnostic and therapeutic methods Apr. 17, 2018
-
Patent Title: Microorganisms for therapy Nov. 15, 2016
-
Patent Title: Modified vaccinia virus strains for use in diagnostic and therapeutic methods Apr. 14, 2015
-
Patent Title: Microorganisms for imaging and/or treatment of tumors Oct. 21, 2014
-
Patent Title: Method for detecting replication or colonization of a biological therapeutic Oct. 14, 2014
-
Patent Title: Microorganisms for imaging and/or treatment of tumors Oct. 07, 2014
-
Patent Title: Microorganisms for therapy Jul. 22, 2014
-
Patent Title: Vaccinia virus for diagnosis and therapy of tumors Feb. 04, 2014
-
Patent Title: Light emitting microorganisms and cells for diagnosis and therapy of tumors Nov. 19, 2013
-
Patent Title: Light emitting microorganisms and cells for diagnosis and therapy of tumors Oct. 29, 2013
-
Patent Title: Methods and compositions for detection of bacteria and treatment of diseases and disorders Jan. 22, 2013
-
Patent Title: Methods and compositions for detection of bacteria and treatment of diseases and disorders Jan. 01, 2013
-
Patent Title: Microorganisms for therapy Dec. 04, 2012
-
Patent Title: Microorganisms for therapy Jul. 17, 2012
-
Patent Title: Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue Mar. 20, 2012
-
Patent Title: Modified vaccinia virus strains for use in diagnostic and therapeutic methods Nov. 29, 2011
-
Patent Title: Modified vaccinia virus strains for use in diagnostic and therapeutic methods Nov. 08, 2011
-
Patent Title: Microorganisms for therapy Sep. 20, 2011
-
Patent Title: Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders Oct. 26, 2010
-
Patent Title: Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders Jul. 27, 2010
-
Patent Title: Microorganisms for therapy Jul. 13, 2010
-
Patent Title: Microorganisms for therapy Feb. 16, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to GNLX
Number of mentions of GNLX in WallStreetBets Daily Discussion
Recent picks made for GNLX stock on CNBC
ETFs with the largest estimated holdings in GNLX
|
Shareholder
|
Shares Held
|
|---|
- Who owns $GNLX stock?
- Who owns the most shares of $GNLX stock?
- What funds own $GNLX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view GNLX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.